GATINEAU, Quebec, June 21, 2018 — / D.M.O. Newswire / — The Hydropothecary Corporation (“THCX” or the “Company”) ( TSXV:THCX ) announced today that it has received approval from the Toronto Stock Exchange (the “TSX”) to graduate from the TSX Venture Exchange (the “TSX-V”) and list its common shares and common share purchase warrants expiring January 30, 2020 on the TSX. The common shares and warrants will commence trading on the TSX effective Friday, June 22, 2018, at which time the Company will also “ring the bell” to open the TSX. In conjunction with listing on TSX, the common shares and warrants will be voluntarily delisted from the TSX-V effective upon commencement of trading on the TSX. “Graduating to a major exchange such as the TSX demonstrates Hydropothecary ’s growth and proven ability to execute,” said Sebastien St-Louis, Hydropothecary’s Chief Executive Officer and co-founder.
“Since 2013, our company has demonstrated our continuous commitment to providing industry-leading, innovative products while never compromising the quality or consistency that we are known for. We are thrilled to represent this on the TSX.”
The common shares and warrants will trade under the symbols “HEXO” and “HEXO.WT” respectively. The Company has previously announced the launch of HEXO as its new brand for the adult-use cannabis market, while continuing to use the Hydropothecary brand for the